BEROTRALSTAT (Orladeyo®)

Clinical Indication

Prevention of recurrent attacks of hereditary angioedema (HEA)

Comments

In line with NICE TA378

Date of classification

September 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.